These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 16856395

  • 1. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G, Wang R, Wang D, Zhang Z, Deng S.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [Abstract] [Full Text] [Related]

  • 2. [Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro].
    Zhang Y, Huang G, Yu Y, Han J, Yu P.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):597-600, 614. PubMed ID: 16856397
    [Abstract] [Full Text] [Related]

  • 3. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
    Khanvilkar KH, Huang Y, Moore AD.
    Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
    [Abstract] [Full Text] [Related]

  • 4. Optimization of sustained release matrix tablet of metoprolol succinate using central composite design.
    Li L, Sun H, Gao J, Jiang T, Gao Y, Zhang J.
    Pak J Pharm Sci; 2013 Sep; 26(5):929-37. PubMed ID: 24035948
    [Abstract] [Full Text] [Related]

  • 5. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ, Windberg-Baarup A, Neri C, Byway PV, Booth SW, Fitzpatrick S.
    Int J Pharm; 2007 Jun 07; 337(1-2):246-53. PubMed ID: 17306477
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH, Tazeen J, Merchant HA, Yousuf RI.
    Pak J Pharm Sci; 2006 Apr 07; 19(2):119-24. PubMed ID: 16751122
    [Abstract] [Full Text] [Related]

  • 7. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S, Bodmeier R.
    Int J Pharm; 2010 Dec 15; 402(1-2):72-7. PubMed ID: 20883759
    [Abstract] [Full Text] [Related]

  • 8. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
    Li FQ, Hu JH.
    Yao Xue Xue Bao; 2004 May 15; 39(5):389-91. PubMed ID: 15338886
    [Abstract] [Full Text] [Related]

  • 9. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR, Choi YW, Cui JH, Lee BJ.
    J Control Release; 2005 Nov 28; 108(2-3):351-61. PubMed ID: 16154656
    [Abstract] [Full Text] [Related]

  • 10. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T, Kanbe H, Okada M, Suzuki M, Ikeda Y, Onuki Y, Kaneko T, Sonobe T.
    Int J Pharm; 2005 Nov 04; 304(1-2):91-101. PubMed ID: 16154302
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.
    Tajarobi F, Abrahmsén-Alami S, Carlsson AS, Larsson A.
    Eur J Pharm Sci; 2009 May 12; 37(2):89-97. PubMed ID: 19429415
    [Abstract] [Full Text] [Related]

  • 12. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug.
    Kranz H, Guthmann C, Wagner T, Lipp R, Reinhard J.
    Eur J Pharm Sci; 2005 Sep 12; 26(1):47-53. PubMed ID: 15953712
    [Abstract] [Full Text] [Related]

  • 13. Formulation development of metoprolol succinate and hydrochlorothiazide compression coated tablets.
    Shah R, Parmar S, Patel H, Pandey S, Shah D.
    Curr Drug Deliv; 2013 Dec 12; 10(6):631-44. PubMed ID: 23017092
    [Abstract] [Full Text] [Related]

  • 14. Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention.
    Narendra C, Srinath MS, Babu G.
    AAPS PharmSciTech; 2006 Apr 07; 7(2):E34. PubMed ID: 16796352
    [Abstract] [Full Text] [Related]

  • 15. Designing HPMC matrices with improved resistance to dissolved sugar.
    Williams HD, Ward R, Culy A, Hardy IJ, Melia CD.
    Int J Pharm; 2010 Nov 30; 401(1-2):51-9. PubMed ID: 20858538
    [Abstract] [Full Text] [Related]

  • 16. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB, Lim J, Kang CY, Lee BJ.
    Curr Drug Deliv; 2013 Dec 30; 10(6):732-41. PubMed ID: 23855499
    [Abstract] [Full Text] [Related]

  • 17. Core-in-cup tablet design of metoprolol succinate and its evaluation for controlled release.
    Nagaraju R, Meera DS, Kaza R, Arvind VV, Venkateswarlu V.
    Curr Drug Discov Technol; 2009 Dec 30; 6(4):299-305. PubMed ID: 20025598
    [Abstract] [Full Text] [Related]

  • 18. The effect of substitution pattern of HPMC on polymer release from matrix tablets.
    Viridén A, Larsson A, Wittgren B.
    Int J Pharm; 2010 Apr 15; 389(1-2):147-56. PubMed ID: 20100556
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T, De Beer T, Vervaet C, Remon JP.
    Eur J Pharm Biopharm; 2009 Jan 15; 71(1):145-54. PubMed ID: 18511248
    [Abstract] [Full Text] [Related]

  • 20. The influence of HPMC viscosity as FRC parameter on the release of low soluble drug from hydrophylic matrix tablets.
    Novak SD, Kuhelj V, Vrečer F, Baumgartner S.
    Pharm Dev Technol; 2013 Jan 15; 18(2):343-7. PubMed ID: 21916601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.